A team of researchers at the University of Georgia College of Veterinary Medicine has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models.
Apr 21, 2020
0
135
A total of 155 drugs and 79 vaccines are currently being developed worldwide to combat COVID-19. The Austrian Institute for Health Technology Assessment (AIHTA) has compiled these astonishing figures as part of a new product ...
Apr 20, 2020
0
23
Three potential COVID-19 vaccines are making fast progress in early-stage testing in volunteers in China and the U.S., but it's still a long road to prove if they'll really work.
Apr 14, 2020
0
7
As labs around the world race to develop a vaccine, my colleagues and I are trying to find a better way to deliver it than the standard, cringe-inducing shot.
Apr 9, 2020
0
2
The University of Bristol and spin-out company Imophoron have announced they are ready to test COVID-19 vaccine candidates in a pre-clinical program.
Apr 8, 2020
0
210
Researchers at the University of Iowa and the University of Georgia have developed a vaccine that fully protects mice against a lethal dose of MERS, a close cousin of the SARS-CoV2 coronavirus that causes COVID-19.
Apr 7, 2020
0
1631
South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 ...
Apr 3, 2020
0
33
University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized ...
Apr 2, 2020
0
7862
Johnson & Johnson said on Monday it had selected a lead candidate vaccine for the new coronavirus that would move to human trials by September and could be ready for emergency use by early next year.
Mar 30, 2020
0
2666
The number of potential therapeutic options for treatment of COVID-19 is growing. Approaches include blocking SARS-CoV-2 from entering cells, disrupting the virus' replication, antivirals, vaccines, and suppressing overactive ...
Mar 26, 2020
0
11
